Isobutyryl-DL-aMeDab(1)-DL-Arg(Me)-DL-Abu-DL-Phg-(1)·TFA is a short peptidomimetic featuring N-methyl and noncanonical residues that impose rigid conformations. The isobutyryl cap and aromatic Phg unit tune hydrophobic character and steric bulk. Researchers explore its binding to structured protein pockets and enzymatic resistance. Applications include lead-scaffold development, conformational analysis, and structure-activity studies.
CAT No: R2371
CAS No:2097887-21-1
Synonyms/Alias:MM-589 TFA;2097887-21-1;MM-589 (TFA);XID88721;DA-65552;N-{6-ethyl-12-methyl-9-[3-(N'-methylcarbamimidamido)propyl]-2,5,8,11-tetraoxo-3-phenyl-1,4,7,10-tetraazacyclotetradecan-12-yl}-2-methylpropanamide; trifluoroacetic acid;
4. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
5. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.